UNSPSC 51312506: Clobenzepam hydrochloride

This classification denotes a histamine-1 receptor antagonist C17H18ClN3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 618Q2FLB9R, chemically known as 2-(2-chloro-6-oxo-11h-benzo(b)(1,4)benzodiazepin-5-yl)ethyl-dimethyl-ammonium chloride, but more generally known as clobenzepam hydrochloride, which bears US NIH Compound Identifier 17646. Most nations, for tariff and trade purposes, schedule clobenzepam hydrochloride under HS 29339940 and SITC 51577.

As of Q4 2014, CLOBENZEPAM HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN(C)CCN1C2CCC(CC2NC3CCCCC3C1=O)CL.CL.

UNSPSC 51312506 Clobenzepam hydrochloride is a Commodity code that in recent state and local procurement activity covers emergency medical supplies and drug-intervention systems rather than the pharmaceutical compound its nominal title suggests. Seminole County, Florida solicited naloxone units and safe drug deactivation systems through competitive bidding, indicating that the code is being used to classify harm-reduction and opioid-response supplies that state and local health departments and county public health agencies procure to support community health and overdose-prevention initiatives. The scope typically includes unit pricing for medical countermeasures and delivery logistics to specified health facilities or community sites.

Seminole County, Florida represents the only recent identifiable state and local opportunity under this code. The county issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bidders were required to submit electronic responses by July 26, 2023, at 2:00 pm, with all shipping and delivery costs included in proposals. The contract carried a two-year initial term with one-year renewal option, fixed-fee pricing, and compliance requirements including drug-free workplace certification, E-Verify authorization, and standard insurance coverages. Geographic activity is limited in the recent-opportunities block to Florida, and issuing-body diversity is not demonstrated by the available record.